The Lancet Medical Imaging & Theranostics
LightNews LightNews
banner
lancetimaging.bsky.social
The Lancet Medical Imaging & Theranostics
@lancetimaging.bsky.social
130 followers 340 following 41 posts
A gold OA journal dedicated to clinical and technological advances in radiology, nuclear medicine, and theranostics.

🌐 www.thelancet.com/medical-imaging-theranostics
Posts Replies Media Videos
Pinned
lancetimaging.bsky.social
The Lancet Medical Imaging & Theranostics @lancetimaging.bsky.social · 25d
📢 We’ve published our first issue!

Read and download our inaugural issue here ➡️ www.thelancet.com/issue/S3117-...

Thank you to our authors and reviewers for their valuable contributions ✨

As a gold open access journal, our content is free to read by everyone, always. #OA

#MedSky #RadSky
Image ALT text: Representative images of individuals with different NMN BBB scores. The left column shows contrast enhanced MRI brain scans and the right column shows the fusion of the MRI scans and PET scans of these same individuals. The top row corresponds to an individual with a NMN BBB score of 2 as minor parts of PET-positive volume show contrast enhancement on MRI. The bottom row corresponds to an individual with a NMN BBB score of 5 as the PET positive volume shows complete contrast enhancement on MRI. Copyright: The authors, Nathalie Albert and colleagues. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Reposted by The Lancet Medical Imaging & Theranostics
thelancet.com
A new AI tool could help doctors avoid unnecessary contrast-dye injections for some brain tumour patients, according to a study in @lancetimaging.bsky.social

Explore the research 👉 tinyurl.com/2uufu6ur
Predicting brain tumour enhancement from non-contrast MRI with artificial intelligence: a multicohort, retrospective, diagnostic accuracy study
Deep learning can identify contrast-enhancing brain tumours from non-contrast MRI. These models show promise as a triage or decision-support aid—for example, flagging studies in which post-contrast en...
tinyurl.com
September 16, 2026 at 8:17 AM
lancetimaging.bsky.social
Our first editorial, in our August issue, presents our vision and hopes for the new journal.

We are all looking forward working with researchers & clinicians to advance imaging and improve health.

Read bit.ly/3VmfOSY
September 10, 2026 at 12:59 PM
lancetimaging.bsky.social
3rd highlight from our August issue
M Dremmen & coll from Erasmus University of Rotterdam present population-based neuroimaging growth curves for children and young adults.

Read bit.ly/4yi81Uq

#neurosky #pedsky
Neuroimaging growth curves in children and young adults aged 6–20 years in the Netherlands: a population-based cohort substudy of the Generation R Study
The developed growth curves provide a quantitative reference framework for paediatric brain development and identify subtle but clinically relevant deviations in specific patient groups, and have the ...
bit.ly
September 3, 2026 at 9:18 PM
lancetimaging.bsky.social
2nd highlight from our August issue
C Lei & coll from Nanjing University evaluated the potential of [18F]FDG-PET–CT-defined complete metabolic response (CMR) to provides complementary prognostic information for patients with renal carcinoma

Read bit.ly/4x3RtPe

#PET #CT #oncsky #cansky #radsky
Prognostic value of 1-year [18F]FDG-PET–CT-defined complete metabolic response in metastatic clear-cell renal cell carcinoma: a multicentre, observational cohort study in China
In patients with mccRCC who remained progression free throughout the first year of first-line ICB-based therapy, 1-year [18F]FDG-PET–CT-defined CMR provided clinically relevant prognostic stratificati...
bit.ly
September 2, 2026 at 2:59 PM
lancetimaging.bsky.social
1st highlight from our August issue
H Einspieler & coll present a secondary analysis of the phase 3 RAPID trial evaluating the potential value of PSMA PET-CT for prostate cancer diagnosis.

Read bit.ly/4zQsK3h

#PET #prostatecancer #openaccess
Representative case of clinically significant prostate cancer
September 1, 2026 at 3:01 PM
Reposted by The Lancet Medical Imaging & Theranostics
lancetrespirmed.bsky.social
🫁 Explore our September 2026 issue, out now in print and online!

🔗 www.thelancet.com/issue/S2213-...

🔹 This issue covers postoperative pulmonary complications, #NSCLC, pulmonary fibrosis of childhood #ILD and much more
Alt: In a children’s activity room, a pair of glass windows forms the shape of lungs, with dust covering the surface to represent pulmonary fibrosis. A child wipes away the dust and reveals other children outside the windows, symbolising the progress made through research and highlighting the need to bring greater attention to children affected by these conditions. Credit: Lillian Li
August 26, 2026 at 1:44 PM
Reposted by The Lancet Medical Imaging & Theranostics
lancetgastrohep.bsky.social
The August 2026 issue of @lancetgastrohep.bsky.social hep.bsky.social is out now at www.thelancet.com/gastrohep!

Content includes #pancreaticcancer, #IBD, eosinophilic #gastritis, #livercancer, #MASLD + more!

#GastroSky #LiverSky #MedSky
July 9, 2026 at 6:44 AM
Reposted by The Lancet Medical Imaging & Theranostics
lancetgastrohep.bsky.social
🆕Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial

www.thelancet.com/journals/lan...

#GastroSky #OncSky #MedSky #AI
Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial
CADe-assisted colonoscopy did not show the absolute improvement in adenoma detection rate that was assumed in the prespecified sample-size calculation. CADx did not clearly improve lesion differentiat...
www.thelancet.com
July 17, 2026 at 5:22 AM
Reposted by The Lancet Medical Imaging & Theranostics
thelancetrheum.bsky.social
Our August 2026 issue is live!

Including research on sacroiliac joint #bonemarrowoedema, a precision medicine tool in #Sjögrens disease, the role of #healthliteracy in #inflammatoryarthritis, plus much more! thelancet.com/journals/lanrhe/home

Cover by @emma-cheng.bsky.social

#Medsky #Rheumsky
July 21, 2026 at 9:42 AM
Reposted by The Lancet Medical Imaging & Theranostics
thelancet.com
🔔 Discover The Lancet Surgery & Anaesthesiology, a new journal with a sharp clinical focus, dedicated to advancing science across the full extent of #surgery, #anaesthesiology, and #perioperative specialties, across the age spectrum, and across the globe: spkl.io/633237JQbc
Illustration of a female in green scrubs, cap, and blue surgical mask, surrounded by four smaller illustrations showing surgical instruments and operating room scenes. Copyright: Grace Russell.
July 23, 2026 at 8:16 AM
Reposted by The Lancet Medical Imaging & Theranostics
thelancetoncol.bsky.social
🆕Our Sept issue is now live!

📊Articles: #hepatocellularcarcinoma #NSCLC #rectalcancer #breastcancer #prostatecancer

📉Featuring trials: EMERALD-3, HARMONi, ALINA, STAR-TREC, & GETUG AFU 18

🎨Cover: breast cancer, TILs, and AI

🖱️Read here: www.thelancet.com/issue/S1470-...
August 25, 2026 at 10:06 AM
Reposted by The Lancet Medical Imaging & Theranostics
eclinicalmed.bsky.social
📢NEW: August issue now online featuring #HepB, #MS, #BreastCancer, #Psoriasis, #COVID, #Psychosis, #MacularOedema, and more, with our editorial on #heatwaves and health system resilience

…all available #free, #OpenAccess❗️

Read here: www.thelancet.com/issue/S2589-...

Attribution: Getty
#MedSky
August 24, 2026 at 11:35 AM
Reposted by The Lancet Medical Imaging & Theranostics
thelancet.com
We're inviting submissions for the 2025 #WakleyPrize Essay Competition.

✍️ Explore this year's theme, put pen to paper, and submit your work today: spkl.io/633267zgsE
Promotional card for The Lancet's Wakley Prize Essay Competition. Text on card reads: The Wakley Prize Essay Competition: A call for submissions. Background image is of Thomas Wakley, who founded The Lancet in 1823.
August 22, 2026 at 8:32 AM
lancetimaging.bsky.social
📢 We’ve published our first issue!

Read and download our inaugural issue here ➡️ www.thelancet.com/issue/S3117-...

Thank you to our authors and reviewers for their valuable contributions ✨

As a gold open access journal, our content is free to read by everyone, always. #OA

#MedSky #RadSky
Image ALT text: Representative images of individuals with different NMN BBB scores. The left column shows contrast enhanced MRI brain scans and the right column shows the fusion of the MRI scans and PET scans of these same individuals. The top row corresponds to an individual with a NMN BBB score of 2 as minor parts of PET-positive volume show contrast enhancement on MRI. The bottom row corresponds to an individual with a NMN BBB score of 5 as the PET positive volume shows complete contrast enhancement on MRI. Copyright: The authors, Nathalie Albert and colleagues. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
August 27, 2026 at 11:15 AM
lancetimaging.bsky.social
📢 We’ve published our first issue!
Thank you to our authors and reviewers for their valuable contributions ✨

As a #goldopenaccess journal, our content is free to read by everyone, always.

Read and download our inaugural issue here ➡️
bit.ly/4y6p9wt

#MedSky #RadSky
Representative images of individuals with different NMN BBB scores. The left column shows contrast enhanced MRI brain scans and the right column shows the fusion of the MRI scans and PET scans of these same individuals. The top row corresponds to an individual with a NMN BBB score of 2 as minor parts of PET-positive volume show contrast enhancement on MRI. The bottom row corresponds to an individual with a NMN BBB score of 5 as the PET positive volume shows complete contrast enhancement on MRI. Copyright: The authors, Nathalie Albert and colleagues. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
August 27, 2026 at 11:12 AM
lancetimaging.bsky.social
🎉Really happy to share our first original research article, ahead of our inaugural issue of the journal.

@guilhermepovala.bsky.social & colleagues from the HEAD study propose a PET–CT pipeline using low-dose CT to quantify tau PET without MRI.

Read #openaccess bit.ly/45KxZUg
#Alzheimers #MRI #PET
August 4, 2026 at 10:04 PM
lancetimaging.bsky.social
📣 The Lancet #MedicalImaging & #Theranostics is now indexed in Crossref. 

We are committed to supporting you on every stage of your publication journey. Learn more about our scope, impact, and global reach: hubs.li/Q04k_6ym0

#OpenAccess #MedSky
The Lancet Medical Imaging & Theranostics promotional graphic: ‘Publish with us—a new open access destination for clinical and technological advances in radiology, nuclear medicine, and theranostics research.’ Copyright: Elsevier Ltd.
July 1, 2026 at 3:02 PM
Reposted by The Lancet Medical Imaging & Theranostics
thelancetoncol.bsky.social
🆕Our July issue is live!

📊Articles: #NSCLC #Breastcancer #prostatecancer #glioblastoma

📉Trials: AENEAS2, SUBITO, EORTC 22922/10925, ARTO, PRIMARY2, CAIRO6, & INTRAGO-II

🎨Cover: Meta-analysis on AEs of CD3 T cell-engaging bispecific abs

Read here: thelancet.com/issue/S1470-...
June 30, 2026 at 9:54 AM
lancetimaging.bsky.social
Attending #RCRGlobalAI in London? Our team, Ali Landman and Ankita Das will be there and available to discuss about our journal, your projects and potential collaborations! Feel free to reach out
June 29, 2026 at 1:20 PM
lancetimaging.bsky.social
💥 Introducing The Lancet Medical Imaging & Theranostics podcast 💥

🎙️ In our debut episode, our Editor-in-Chief is joined by Dr Preusser and @nathaliealbert.bsky.social to discuss insights from the @nmnsymposium.bsky.social.

🎧 Listen to the episode
bit.ly/49F56LM
Nathalie Albert and Matthias Preusser on the NMN-BBB score | The Lancet Medical Imaging and Theranostics Podcast
Professor Matthias Preusser (Medical University of Vienna, Austria) and Professor Nathalie Albert (LMU University Hospital, Munich, Germany) join Editor-in-Chief Ali Landman to discuss the Nuclear Med...
bit.ly
June 4, 2026 at 7:20 PM
lancetimaging.bsky.social
Hope you are enjoying #SNMMI2026 and/or #ASCO2026!
Feel free to reach out directly to discuss potential submissions!
June 1, 2026 at 2:49 PM
lancetimaging.bsky.social
📣 Just in time for #ASCO2026 & #SNMMI2026...

Read a new Comment from Keamogetswe Ramonaheng and Mike Sathekge at NuMeRI on the crucial role of dosimetry in delivering truly personalised treatments in oncology

Read for free: www.thelancet.com/journals/lan...
Dosimetry as the compass of radiotheranostics: from fixed activity to true precision
Radiopharmaceutical therapy stands at a decisive crossroads. After decades of administering mostly fixed or weight-based activities (the amount of radioactivity administered to a patient),1,2 the scie...
www.thelancet.com
May 29, 2026 at 2:21 PM
Reposted by The Lancet Medical Imaging & Theranostics
thelancetoncol.bsky.social
Heading to #ASCO26? Reach out to Dr David Collingridge, Editor-in-Chief at @thelancetoncol.bsky.social, attending #ASCO26

🗓️ Attend the Global Oncology: A Workforce Crisis—A Lancet Oncology Commission session May 31, 2026, 4:30 PM-5:45 PM CDT #cancerworkforce

meetings.asco.org/meetings/202...
May 28, 2026 at 1:01 PM
lancetimaging.bsky.social
Our deputy editor, Pierre Nauleau, will attend #AIUM the #Ultrasound conference in Philadelphia later this week. Please reach out if you want to meet and discuss your research!

@aiumultrasound.bsky.social
May 27, 2026 at 5:21 PM
Reposted by The Lancet Medical Imaging & Theranostics
thelancetoncol.bsky.social
🆕 Greater transparency for oncology clinical trials reporting

Chief Editors of The Lancet’s specialty journals discuss enhanced scrutiny in the reporting of oncology clinical trials

Read here: thelancet.com/journals/lan...
February 4, 2026 at 9:57 AM